Search academic texts

Information × Registration Number 0213U008045, 0108U011005 , R & D reports Title Differential lipidcorrective treatment in the patients with ischemical heart disease. popup.stage_title Head Zolotariova Natalia Artemovna, Registration Date 03-12-2013 Organization Odesa National Medical University popup.description2 The study involved 455 patients with stable angina, and arterial hypertension. Atorvastatin reduced total cholesterol, ?-lipoprotein, low density lipoprotein (LDL) levels, reduced endothelial dysfunction, but did not affect triglyceride (TG) and high density lipoproteins (HDL). Adding fenofibrate corrected all lipid parameters except HDL, but had a negative effect on lipid peroxidation and increased the frequency of side effects. Consumption of "Berezovska" mineral water eliminated treatment-induced side effects. The use of statins with omega-3 PUFA reduced the level of total cholesterol, LDL, ULDL and TG levels. Metabolic cytoprotector mexicor enhanced the effect of statin therapy and lead to normalization of TG. Adding magnetic therapy also contributed to HDL level elevation. Discovered dynamics of protein and non-protein SH-, S-S groups and the SH/SS coefficient in patients with different forms of ACS was specific enough for being used as additional diagnostic criteria Product Description popup.authors Волковинська Тетяна Василівна Золотарьова Ксенія Олегівна Золотарьова Наталія Артемівна Ковалевська Людмила Андріївна Костюшова Наталія Володимировна Медянка Юрій Степанович Пахомова Олена Олегівна Писковацький Павло Михайлович Романченко Максим Ігорович Соломко Олена Володимирівна Юрлов Владислав Михайлович popup.nrat_date 2020-04-02 Close